Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
NEWS
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...
Glycomine Begins Global Phase 2b Clinical Trial of GLM101 for...
Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
Case Study: PostNord TPL ensures GDP compliance with Vaisala’s...
PostNord TPL, part of the PostNord Group, operates one of the largest third-party logistics...